Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection-Reference-Cited by-同舟云学术

Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection

Published:1999-04 Issue:4 Volume:6 Page:660-666
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

BouHamdan M,Duan L-X,Pomerantz R J,Strayer D S

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3300864.pdf

Reference38 articles.

1. Morsy MA, Mitani K, Clemens P, Caskey CT . Progress toward gene therapy J Am Med Assn 1993 270: 2338–2344

2. Miller AD, Miller DG, Garcia JV, Lynch CM . Use of retroviral vectors for gene transfer and expression Meth Enzymol 1993 217: 581–599

3. Mulligan RC . The basic science of gene therapy (review) Science 1993 260: 926–932

4. Strayer DS . SV40 as an effective gene transfer vector in vivo J Biol Chem 1996 271: 24741–24746

5. Strayer DS, Kondo R, Milano J, Duan L-X . Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells Gene Therapy 1997 4: 219–225

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Current Cell-Penetrating Antibody Developments for HIV-1 Therapy;Molecules;2018-02-06

2. Current progress and challenges in HIV gene therapy;Future Virology;2011-11

3. The use of cell-delivered gene therapy for the treatment of HIV/AIDS;Immunologic Research;2010-08-25

4. HIV-1 IN Inhibitors: 2010 Update and Perspectives;Current Topics in Medicinal Chemistry;2009-08-01

5. HIV-1 Gene Therapy at Pre-Integration and Provirus DNA Levels;Current Gene Therapy;2009-02-01